Questions a plan sponsor actually asks.
What is Bismuth Subcitrate Potassium, Metronidazole, Tetracycline used for?
Bismuth Subcitrate Potassium, Metronidazole, Tetracycline treats anaerobic bacterial and parasitic infections.
Is there a generic for Bismuth Subcitrate Potassium, Metronidazole, Tetracycline?
Yes. 2 ANDAs filed at FDA, 2 generic manufacturers currently shipping.
How much does my plan pay for Bismuth Subcitrate Potassium, Metronidazole, Tetracycline?
Across 329 Part D plans, Bismuth Subcitrate Potassium, Metronidazole, Tetracycline averages $3.15/unit (NADAC). Lowest available: $3.15/unit. Highest in distribution: $3.15/unit.
Is Bismuth Subcitrate Potassium, Metronidazole, Tetracycline on the FDA shortage list?
No. Bismuth Subcitrate Potassium, Metronidazole, Tetracycline is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (3 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.